1 recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Recruiting 1 |
Follow Plasma Cell Leukemia (PCL): new trials by email Literature Review of Plasma Cell Leukemia (PCL) trials Research Report on Plasma Cell Leukemia (PCL)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Personalising Treatment for Myeloma Patients Based on Initial Response to NHS Treatment and Their Overall Fitness Level Daratumumab, Lenalidomide, Dexamethasone - Multiple Myeloma (MM), Plasma Cell Leukemia (PCL) | Phase 3 | Recruiting | University of Leeds | 1226 | 2026-07-01 | 2026-07-15 |
Frailty (1) · Leukemia, Plasma Cell (1) · Multiple Myeloma (1) · Neoplasms, Plasma Cell (1)
Blood Protein Disorders (1) · Cardiovascular Diseases (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Hemorrhagic Disorders (1) · Hemostatic Disorders (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Leukemia (1) · Lymphoproliferative Disorders (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Paraproteinemias (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Dexamethasone (1) · Focal Adhesion Protein-Tyrosine Kinases (1) · Fumigant 93 (1) · Lenalidomide (1) · daratumumab (1) · darlin protein, Dictyostelium (1) · talquetamab (1)
United Kingdom (1)
Charlotte Pawlyn (1) · Gordon Cook (1)